Adragos Pharma vs Ascendia Pharmaceutical Solutions
Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.
Markdown mirror: /api/markdown/compare/adragos-pharma/ascendiacdmo
| Category | Adragos Pharma | Ascendia Pharmaceutical Solutions |
|---|---|---|
| Listed site | cdmo | cdmo |
| Summary | Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan. | Ascendia is a specialty CDMO providing formulation development, analytical services, and GMP manufacturing for small molecules and biologics from pre-formulation through commercialization, with proprietary nanotechnologies including LipidSol, EmulSol, AmorSol, and NanoSol. |
| Services |
|
|
| Modalities |
|
|
| Indications |
| Data not yet provided. |
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |